Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intel: Peripheral Nerve Stim Players Edge Out Innovative Paths

Executive Summary

While demand for spinal cord stimulation (SCS) devices used in pain management continues to expand at double-digit rates, a small but growing number of highly innovative companies that develop stimulators to specifically target peripheral nerve pain is creating excitement among pain doctors looking for better options to treat an intractable population that's seen little success with standard therapy. With millions of people worldwide suffering from low back pain, severe headaches and migraines, neck pain and other chronic pain, the demand for safe, effective, percutaneously-placed devices remains high. In this article, we'll highlight emerging companies working on PNS devices and provide insights from pain physicians on the pros and cons of these devices.

Advertisement

Related Content

FDA Issues Challenge To Medtech To Fight Opioid Crisis
Bills Advancing In US Congress Would Hasten FDA Reviews Of Non-Opioid Medtech Alternatives
Mainstay Will Supplement Australian ReActiv8 Application With ReActiv8 B Data
GSK Consumer Tries On Wearable Pain Relief With NeuroMetrix Deal
Mainstay Medical Reaches Milestone With Interim Results Of US Clinical Trial
OUS Approvals: Neurostim And Cardiovascular Lead June Surge
INS 2017: Neuromodulation's Future Features Innovative Power Source, Materials And Treatment Protocols
SPR Therapeutics: Peripheral Nerve Stimulation To Treat Pain

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT122849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel